Heat-inactivated modified vaccinia virus Ankara (MVA) as vaccine adjuvant

被引：0
|
作者：
Yang, Ning [1 ]
Shuman, Stewart [1 ]
Merghoub, Taha [1 ]
Wolchok, Jedd [1 ]
Deng, Liang [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P116
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Construction of Recombinant Modified Vaccinia Ankara(MVA) Expressing Hepatitis B Virus Surface Antigen
    CHEN Yu
    Chemical Research in Chinese Universities, 2006, (02) : 213 - 216
  • [22] Construction of recombinant modified vaccinia Ankara(MVA) expressing hepatitis B virus surface antigen
    Chen, Y
    Yang, XS
    Yu, XH
    Jiang, CL
    Wu, YG
    Jin, YH
    Chen, Y
    Chen, Y
    Li, W
    Kong, W
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2006, 22 (02) : 213 - 216
  • [23] Skin delivery of modified vaccinia ankara (MVA) virus generates superior protective pulmonary immunity
    Pan, Y.
    Tian, T.
    Park, C.
    Stingley, C. A.
    de Masson, A.
    Kupper, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S15 - S15
  • [24] Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
    Garcia-Arriaza, Juan
    Esteban, Mariano
    Lopez, Daniel
    BIOMEDICINES, 2021, 9 (09)
  • [25] Cardiac Safety in Clinical Trials with Preventive HIV Vaccine Candidates Based on Modified Vaccinia Ankara (MVA)
    Schmidt, C.
    Kochhar, S.
    Excler, J.
    Smith, C.
    McMichael, A.
    Hanke, T.
    Bwayo, J.
    Jaoko, W.
    Weber, J.
    Kaleebu, P.
    Peters, B.
    Pantaleo, G.
    Vardas, E.
    Vasan, S.
    Keefer, M.
    Ramanathan, V.
    Boyle, R.
    Fast, P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 106 - 107
  • [26] Improving the immunogenicity of modified vaccinia virus Ankara (MVA) vaccine vector by deletion of the vaccinia E5R gene encoding a dominant cGAS inhibitor
    Deng, Liang
    Yang, Ning
    Wang, Yi
    Dai, Peihong
    Shuman, Stewart
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [27] Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
    Kreijtz, J. H. C. M.
    Suezer, Y.
    de Mutsert, G.
    van den Brand, J. M. A.
    van Amerongen, G.
    Schnierle, B. S.
    Kuiken, T.
    Fouchier, R. A. M.
    Loewer, J.
    Osterhaus, A. D. M. E.
    Sutter, G.
    Rimmelzwaan, G. F.
    VACCINE, 2009, 27 (45) : 6296 - 6299
  • [28] Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
    Brewoo, Joseph N.
    Powell, Tim D.
    Jones, Jeremy C.
    Gundlach, Nancy A.
    Young, Ginger R.
    Chu, Haiyan
    Das, Subash C.
    Partidos, Charalambos D.
    Stinchcomb, Dan T.
    Osorio, Jorge E.
    VACCINE, 2013, 31 (14) : 1848 - 1855
  • [29] Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine
    Zhou, Ya Bin
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12):
  • [30] Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
    Czub, M
    Weingartl, H
    Czub, S
    He, RT
    Cao, JX
    VACCINE, 2005, 23 (17-18) : 2273 - 2279
12345